Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Jamie Y. Story, Jaquelyn T. Zoine, Rebecca E. Burnham, Jamie A.G. Hamilton, H. Trent Spencer, Christopher B. Doering, Sunil S. Raikar
Topics & Concepts
NKG2DBortezomibCancer researchCytotoxic T cellMyeloid leukemiaImmune systemT cellEx vivoLeukemiaImmunologyMedicineBiologyIn vivoIn vitroMultiple myelomaBiotechnologyBiochemistryImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology